市場調查報告書

經腸營養製劑市場預測:各產品類型 (標準製劑,疾病專一製劑),各用途,各地區

Enteral Feeding Formula Market: By Type, by Age, by form, by Flavor, by Mode of Delivery by Geography - Forecast 2018-2023

出版商 IndustryARC 商品編碼 422170
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
Back to Top
經腸營養製劑市場預測:各產品類型 (標準製劑,疾病專一製劑),各用途,各地區 Enteral Feeding Formula Market: By Type, by Age, by form, by Flavor, by Mode of Delivery by Geography - Forecast 2018-2023
出版日期: 2018年12月21日內容資訊: 英文 120 Pages
簡介

本報告提供全球經腸營養製劑市場相關調查分析,提供市場形勢,市場動態,策略性分析,市場分析 (各市場區隔),再加上主要企業等相關的系統性資訊。

第1章 經腸營養製劑:市場概要

第2章 摘要整理

第3章 經腸營養製劑:市場形勢

  • 市場佔有率分析
  • 比較分析

第4章 經腸營養製劑:市場動態

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題
  • 波特的五力分析

第5章 經腸營養製劑市場:策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品/市場生命週期分析
  • 供給業者·經銷商

第6章 經腸營養製劑市場:各產品類型

  • 標準製劑
  • 疾病專用特殊製劑

第7章 經腸營養製劑市場:各治療領域

  • 腫瘤
  • 消化器官
  • 神經
  • 重症加護診療
  • 其他

第8章 經腸營養製劑市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第9章 市場熵

第10章 企業簡介

  • Abbott Laboratories
  • Nestle S.A.
  • Danone
  • Fresenius Kabi
  • Mead Johnson Nutrition Company
  • B.Braun
  • Victius Inc.
  • 明治集團
  • Global Health Product Inc.
  • Merck & Co., Inc.

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Enteral Feeding Formula Market Overview:

With the increasing geriatric population, increasing chronic diseases and premature births, the growth in enteral feeding formula market have been increased. U.S. leads global enteral feeding market with a huge contribution towards the market, valued at $1870.2 million in 2017 and is estimated to grow to $2647.7m in 2023 at a CAGR of 5.6% during the forecast period 2018-2023.The standard formula segment holds largest part in the revenue of Enteral feeding market with almost 64.3% of total revenue.

Enteral Feeding Formula Market Outlook:

The growth of Enteral feeding formula market has been increased because of increase in patients affected by chronic diseases, preterm births and so on. Based on the condition of the patient, different types of formulas are being provided through different types of feeding tubes. Standard formulas provide nutrition, while semi-elemental formulas provide nutrients along with proteins and fats broken down into small pieces making it easy for digestion. Specialized formulas are to those who are allergic to certain foods and to those who are suffering with Crohn's disease and could not digest fat and protein properly. Also modular products are available that may be added to formula to those who need additional nutrition. These formulas are available in both powder and liquid form. Standard formulas has certain ingredients like Corn syrup solids, glucose, fructose, maltodextrin, lactal bumin, casein, soy protein isolate, whey protein, corn oil, canola oil, meat ingredients and such others. The global enteral formulas are priced in the range of $2 to $10. The highest price of enteral formulas was ranged at 10 dollars for Specialty formulas.

Enteral Feeding Formula Market Growth drivers:

Increase in the patients suffering with cardiovascular diseases, cancer and diabetes which are the leading death causing diseases, has driven the enteral feeding formula market. According to World Health organization (WHO), 17.9million people died from cardiovascular diseases. The patients in ICUs are not comfortable in taking food orally therefore it will become necessary to give the required nutrients through enteral feeding. Also, with the increased quality of the diet provided through tube feeding, the consumers of the enteral feeding market has been increasing drastically. With the increase in geriatric population, the need for tube feeding has also been increasing, as they cannot be able to consume their food orally.

Enteral Feeding Formula Market Challenges:

Huge varieties of formulas are available for feeding in enteral procedures and usage of one formula to a person who is not suitable for that formula results in certain side effects. Certain types of peoples are allergic to certain proteins, fatty acids (Food Allergies from offenders like milk and lactose, corn, eggs, tree nuts, soy, wheat and gluten, fish and shellfish) and are required to take the formulas that are suitable for his or her condition. Thus complexity in selection of the right formula is reducing the growth of the market.

Developing a quality assured formula requires a high level of research and development as the formula delivered through the pipe must provide the enough nutrition to the body as per the requirement and the state of condition of condition of the body without effecting the recovery process. This could be a great challenge to the market with the need to satisfy all the regulatory norms. Also, expenditure in such research and development process could be a considerable issue for the startup companies.

Enteral Feeding Formula Market

Enteral Feeding Formula Market Research Scope:

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Enteral feeding formula market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of formulas in the Enteral feeding formula market and their specific Therapeutics based on different types of requirements.

Enteral Feeding Formula Market Report: Industry Coverage:

Enteral Feeding Formula Market - By type: Standard formula, Specialty formula, Blenderized formula, elemental formula, semi-elemental formula, polymeric formula, Fiber supplemented formula and others

Enteral Feeding Formula Market - By Age Category: adults and children

Enteral Feeding Formula Market - By Flavor type: Vanilla, Strawberry, Butter pecan and unflavored.

Enteral Feeding Formula Market - By Form: Powder, liquid and others

Enteral Feeding Formula Market - By Mode of delivery: oral, gastric. Trans-pyloric

Gastrointestinal disease, Neurological impairment, Pulmonary disease, congenital heart disease, Diabetes, Kidney failure, Liver disorders, Cystic fibrosis, Crohn's disease, Choanal atresia, Malabsorption and so on.

Enteral Feeding Formula Market - By Therapeutic area: Gastrointestinal disease, Neurological impairment, Pulmonary disease, congenital heart disease, Diabetes, Kidney failure, Liver disorders, Cystic fibrosis, Crohn's disease, Choanal atresia, Malabsorption and so on.

The Enteral Feeding Formula market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia.

Enteral Feeding Formula Market Key Players Perspective:

Some of the Key players in this market that have been studied for this report include:

Abbott laboratories, Nestle S.A., DANONE S.A., Novartis AG, Mead Johnson Nutrition Company, Hormel Foods LLC, Victus Inc., Meiji Holdings, Fresensis Kabi AG, B. Braun Melsungen AG and some other players.

Market Research and Market Trends of Enteral Feeding Formula Market:

Neocate LCP is a product for children and teens with cow's milk allergy was launched in 2017 by Danone S.A., one of the key players of the Enteral Feeding Formula market. According to Danone S.A. it is the first and only hypo-allergic and ready-to-use amino acid based formula for children and teenagers with cow's milk or multiple food allergies, available in powder form.

Arginine enriched enteral formula was found to be capable of providing a desired result in the healing of pressure ulcers. It was also found it not only good in healing nourished patients, but also non-nourished patients.

Nestle Health Science, one of the key players in the market, opened a global R&D center in Bridgewater, N.J., U.S.A. on Dec 3rd, 2018. The establishment of the Research Center has been funded with the investment of USD $70 million, completed successfully after 3 years. This advances the offerings by the company to the power of nutrition to the people. It also accelerates the innovations in Consumer care, Medical Nutrition and Novel Therapeutic Nutrition.

Abbott, one among the key players of the market, introduces two Science-Based Nutrition drinks which helps the patients in recovering better from Surgeries. Ensure Surgery Immunonutrition Shake and Ensure Pre-Surgery Clear Nutrition Drink helps in faster development of immunity before and after the surgical procedures.

1. Enteral Feeding Formula - Market Overview

2. Executive Summary

3. Enteral Feeding Formula - Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. End User Profiling
    • 3.2.3. Top 5 Financials Analysis

4. Enteral Feeding Formula - Market Forces

  • 4.1. Drivers
    • 4.1.1. Rising prevalence of chronic diseases
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Force Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Customers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Enteral Feeding Formula Market - Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Enteral Feeding Formula Market, By Product type

  • 6.1. Standard formula
  • 6.2. Disease specific formulas

7. Enteral Feeding Formula Market, By Therapeutic area

  • 7.1. Oncology
  • 7.2. Gastroenterology
  • 7.3. Neurology
  • 7.4. Critical care
  • 7.5. Others

8. Enteral Feeding Formula Market, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. US
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. Europe
    • 8.3.1. U.K
    • 8.3.2. France
    • 8.3.3. Germany
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe
  • 8.4. Asia Pacific
    • 8.4.1. China
    • 8.4.2. South Korea
    • 8.4.3. Japan
    • 8.4.4. India
    • 8.4.5. Rest of Asia Pacific
  • 8.5. RoW

9. Market Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply - Contract

10. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)

  • 10.1. Abbott Laboratories
  • 10.2. Nestle S.A.
  • 10.3. Danone
  • 10.4. Fresenius Kabi
  • 10.5. Mead Johnson Nutrition Company
  • 10.6. B.Braun
  • 10.7. Victius Inc.
  • 10.8. Meiji Holdings Co., Ltd.
  • 10.9. Global Health Product Inc.
  • 10.10. Merck & Co., Inc.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Expert Insights
Back to Top